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A number of different compounds, including phenobarbital, hypolipidemic drugs such as clofi-
brate and nafenopin, the sex steroids progesterone, cyproterone acetate, estradiol and mestranol,
chlorinated hydrocarbons such as DDT, hexachlorocyclohexane, and TCDD and the antioxidant bu-
tylhydroxytoluene, appears to promote the development of liver tumors from previously induced ini-
tiated cells. The mechanisms of tumor promotion by several representative prototypes of these com-
pounds were studied in rat liver in vivo.
All liver tumor promoters mentioned above stimulate growth of normal liver. The growth
response is due to cellular hypertrophy and/or increased rate of DNA (and cell) replication and/or
decreased rate of cell death.
Hepatocytes in foci or islands of altered cells (putatively preneoplastic) show higher rates of repli-
cation than normal liver cells; various different liver tumor promoters cause a further increase of
proliferation of focal cells. The increased proliferative activity is found in different island pheno-
types and thus seems to be a useful marker of the putative preneoplastic state. The focal cells re-
spond to several factors limiting proliferation in normal liver, suggesting that they are not autono-
mous with respect to growth control.
Early preneoplastic foci grow slowly without promotion, despite the relatively high rates of cell
replication. Thus their cells seem to have a much shorter life-time than normal hepatocytes or to un-
dergo reversion to the normal phenotype. Promoters seem to accelerate island enlargement by in-
creasing cell replication and delaying cell death or remodeling. Thus, tumor promoters enhance the
manifestation of the proliferation advantage of the putative initiated cell population.
In addition, promoters cause increases in the number of detectable islands. This can partially be
explained by enlargement of existing islands, but phenotypic changes that would enhance the prob-
ability of detection of remodelling islands and growth of dormant initiated cells, probably contri-
bute to the apparent increase of island number.
Putative preneoplastic foci of unknown origin are frequent in the liver of aged Wistar rats. They
are morphologically and functionally very similar to those induced by carcinogens and are respon-
sive to the mitogenic effect of tumor promoters. Promotion of these "spontaneous" foci may explain
tumor appearance after long-term application of promoters.
The findings may provide a basis for improved identification of initiated hepatocytes (and of initi-
ating hepatocarcinogens) and for detection of tumor promoters. All suspected liver tumor promoters
tested so far induced enhanced preneoplastic cell proliferation after single doses. The long-term
carcinogenicity bioassay as currently performed does not discriminate between initiating and
promoting properties of a test compound if the animals used develop spontaneous preneoplastic
lesions in the organ affected.
Introduction
A variety of compounds has been shown to accel-
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compound itself. Examples are listed in Table 1.
These findings suggested tumor-promoting activity
of the test compounds (1-4). However, most of the
agents were hepatotumorigenic also if given with-
out pretreatment with an initiating carcinogen (5).
Observations of this type cast serious doubts on the
interpretation that the agents are (pure) tumor pro-
moters and have even prevented the general accep-
tance of the initiation-promotion concept in chemical
(liver) carcinogenesis. In fact, we have recently
shown with the a-isomer of hexachlorocyclohexane
(HCH) as a model compound that discrimination
between initiating and promoting properties can be
impossible on the basis of the long-term car-
cinogenicity bioassay alone (4).
Obviously improved knowledge of the mecha-
nisms of tumor promotion is required to develop
methods for detection of promoting compounds
which would be more reliable and more rapid than
the classical long-term bioassay. Better under-
standing of tumor promotion would also appear to
be necessary for reliable assessment of potential
health risks resulting from use of promoting com-
pounds. We will present a short overview on
studies performed by us during the past several
years on three questions pertinent to the mecha-
nisms of tumor promotion in the liver: properties of
tumor promoters relevant to the promoting action;
properties of the initiated cells relevant to promo-
tion; and how "pure" promoters (if they exist) may
lead to tumor appearance in the liver.
Tumor promotion includes as an essential compo-
nent the proliferation of the pool of initiated he-
patocytes. Thus understanding the control of cell
proliferation in normal liver and its disturbance in
initiated cells is of crucial importance to the elucida-
tion of the mechanism of tumor promotion. There-
fore, some aspects of growth control in the liver will
also be considered.
It should be noted that by definition complete he-
patocarcinogens and also toxic agents such as CCI4
possess tumor-promoting activity in the liver. Ef-
fects of these agents are not considered in the pres-
ent paper.
Methods
Female Wistar rats (Zentralinstitut fur Versuchs-
tierzucht, Hannover, Germany) were used at an ini-
tial age of 4 to 8 weeks unless stated otherwise.
Where indicated, the animals were adapted for 3
weeks to a controlled lighting rhythm (light-dark
12-12) and to a daily feeding period of 5 hr. This
regimen served to synchronize endogenous and mi-
togen-induced DNA synthesis in the liver (6). For in-
duction of putative preneoplastic foci, 75 or 150
mg/kg diethylnitrosamine (DENA) or 250 mg/kg N-
nitrosomorpholin (NNM) was dissolved in water and
administered as single oral doses. Hepatomitogen-
ic/promoting compounds were given as follows: Phe-
nobarbital (PB) orally, 1 x 50 mg/kg in aqueous so-
lution or daily 50 mg/kg via the food; a-hexachloro-
cyclohexane (a-HCH) orally, 1 x 200 mg/kg in oil or
daily 20 mg/kg via the food; cyproterone acetate
(CPA) orally in oil, 40 or 100 mg/kg once or daily or
100 mg/kg once weekly; progesterone (Pro) SC 500
mg/kg once weekly; ethinylestradiol (EE2) SC in
oil/benzyl benzoate 0,5 mg/kg daily. 3H-thymidine
(0.2 mCi/kg) was injected IV to measure DNA
synthesis; clock times of injection were scheduled to
the period of maximal DNA synthesis during the
daily rhythm (6).
After decapitation, specimens of liver tissue
were fixed in formalin or cold acetone, and histologi-
cal sections were prepared by standard procedures
and stained with hematoxylin and eosin or were as-
sayed for y-glutamyltransferase (y-GT) activity (7).
Autoradiography was performed on the same sec-
tions to measure DNA synthesis, which was deter-
mined by counting labeled cells (3H-index = percent
Table 1. Compounds believed to promote tumor development in rodent liver
and their acute hepatic effects.
Class Compounda Increased synthesis of Proliferation ofb Growth
Sedatives Phenobarbital Monooxygenase (PB-
type) SER +
Estrogens Estradiol Various serum +
Ethinylestradiol/mestranol proteins
Progestins Progesterone Monooxygenase SER +
Cyproteronacetate (= CPA) (PCN-type)
Hypolipidemic drugs Nafenopin, Clofibrate Enzymes of fatty Microbodies +
acid metabolism
Chlorinated hydrocarbons Hexachlorocyclohexane Monooxygenase SER +
(= HCH), DDT, PCB's, TCDD (PB, MC-type)
Antioxidants Butylhydroxytoluene Monooxygenase SER +
aPB = phenobarbital; PCN = pregnenolone-16 a= -carbonitrile; MC = 20-methylcholanthrene.
bSER = smooth endoplasmic reticulum
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of hepatocytes labeled). Biochemical determination
of DNA content and of the specific activity of DNA
was done as described previously (6, 8) using the
procedure of Burton (9).
Results and Discussion
Effects of Tumor Promoters in Normal Liver
A central question in tumor promotion concerns
the properties of tumor promoters relevant to the
promoting action. The biological effects of putative
tumor promoters in normal liver might provide a
first clue to identify the critical properties. As is oW
vious from the compilation show in Table 1, liver tu-
mor promoters tentatively identified so far are ex-
tremely heterogeneous with respect to chemical
structures and general pharmacological or biological
effects. They share, however, the ability to induce
in the liver increases of specific functions and
growth, often considered to be adaptive responses
to the agent. Functional changes include increased
synthesis of certain serum proteins or of enzyme
families such as drug-metabolizing enzymes or en-
zymes of the fatty acid metabolism. These changes
are frequently accompanied by multiplication of spe-
cific organelles such as smooth endoplasmic reticu-
lum (SER) or microbodies. The third component of
the adaptive response is the induction of liver
growth (5, 10). Indeed, stimulation of liver growth
appears to be the only known effect common to all
the various tumor promoters listed in Table 1. Like-
wise, in various other organs, compounds promoting
tumor development also stimulate growth of that
organ. It therefore seemed justified to adopt the
hypothesis that the ability to induce growth is one
of the critical properties of tumor promoters. Fur-
ther evidence supporting this hypothesis will be
presented below.
How is the growth response of the liver brought
about? With most of the compounds mentioned in
Table 1 it is due to a combination of cellular hyper-
trophy and hyperplasia, the contribution of which to
the total enlargement of the liver varies consider-
ably depending on the specific compound and the
experimental conditions (5, 10). As an example, Fig-
ure 1 depicts the effects of ethinylestradiol (EE2) on
the liver. This estrogen is most frequently used in
human contraceptive formulations; its effects on
liver growth were studied recently in some detail
(11). That estrogens may cause growth of rodent
liver was observed several years ago (12), but no at-
tention was paid to these findings. As shown in the
upper part of Figure 1 the effect of EE2 on liver size
is moderate if compared to controls fed ad libitum,
and this may be the reason why the profound stimu-
latory effect of estrogens on liver growth have been
overlooked by most investigators. Estrogens de-
crease food consumption, and this results in a de-
crease of liver size (Fig. 1). Thus, if liver mass after
EE2 treatment is compared to that in pair-fed con-
trol animals, a very pronounced increase of about
80% is seen. This increase is accompanied by a
steep increase of hepatic DNA synthesis, with a
peak on the first day after start of treatment and a
subsequent decline almost back to control values
during the ensuing seven days. This increase which
by histological-autoradiographic studies has been
found to be predominantly due to parenchymal
DNA synthesis results in a considerable increase of
hepatic DNA content (Fig. 1, lower part). Mitotic ac-
tivity is also increased (data now shown.)
It should be noted that the increase of DNA
synthesis declines almost to control values even
though EE2 treatment is continued. The same has
been found with cyproterone acetate (CPA) (Fig. 2),
and with all other hepatomitogens/tumor promoters
tested so far (5, 8, 10). Obviously an effective feed-
back mechanism prevents excessive accumulation of
DNA in response to mitogenic stimuli. Figure 2 also
presents another important aspect of mitogen ac-
tion. It can be seen that the increased content of
DNA persists as long as the treatment is preformed.
However, if the treatment is stopped, the DNA con-
tent of the liver declines rapidly in a matter of a
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few days and then more slowly until eventually the
control level will be reached. It appears that in the
hyperplastic liver at least some of the cells depend
on the continuous presence of the growth stimulus;
its withdrawal causes rapid death of some of the
cells (Fig. 2) (13). In summary, CPA as well as the
other compounds studied so far appear to stimulate
liver growth by hypertrophic and/or mitogenic ef-
fects on hepatocytes and to maintain cell number at
an enhanced level by preventing cell death. These
effects are well known actions ofvarious trophic hor-
mones in their target organs, and it may be con-
cluded that the liver mitogens/promoters studied
have a hormonelike effect on the normal liver.
Short-Term Effects of Promoters on
Proliferation in Foci of Altered Cells
A second question central to understanding tu-
mor promotion concerns identification and
properties of the target cell of promoters from
which tumors eventually arise. According to the
two-stage concept, this cell should be the initiated
cell, which unfortunately has not yet been identified
in the liver or other organs. There is, however,
rather strongevidence suggestingthat fociorislands
of phenotypically altered cells appearing in the liver
of carcinogen-treated animals are the immediate
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progeny of the initiated cell. Consequently we have
studied the effect of the tumor promoters on these
altered, putatively preneoplastic (pn) cells, and par-
ticular attention was paid to the growth behavior of
these cells. Rats were treated with single doses of
DENA or NNM, and after 3 weeks to 11 months, is-
lands were identified by means of a positive y-
glutamyltransferase (yGT) reaction, increased baso-
philia or clearness of cytoplasm (14-16).
It is important to note that this regimen of initia-
tion results in appearance of neoplastic nodules or
carcinomas in the liver only after more than 1 or 2
years, if no promoters are applied. The pn lesions in-
duced thus appear to be in an early stage of tumor
development. Invariably the island cells exhibited
higher rates of DNA synthesis and mitotic activity
than the normal hepatocytes (Fig. 3). Obviously the
rate of proliferation within the islands is above the
needs for homeostasis of cell number in the whole
liver. Single doses of various types of tumor pro-
moters resulted in a further increase of the already
enhanced proliferation activity of island cells. The
increased proliferative activity was found in differ-
ent island phenotypes (17) and thus seems to be a
marker more consistently associated with the puta-
tive pn state than the morphological and histochem-
ical alterations often used.
Long-Term Effects of Promoters on Islands
of Altered Cells
Islands of altered cells exhibited increased rates
of DNA synthesis at all times investigated between
three weeks and 11 months after administration of
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FIGURE 2. Effects of cyproterone acetate treatment and
withdrawal on DNA content and DNA synthesis of rat
liver. Daily dose, 40 mg/kg CPA
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FIGURE 3. DNA synthesis and mitotic activity in foci of y-GT
positive cells following single doses of various suspected
liver tumor promoters. PCN = pregnenolone-16a-carboni-
trile, 100mg/kg; nafenopin: 100 mg/kg; CPA: 100 mg/kg;
other doses, see text.
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the carcinogen (Figs. 4 and 5). Assuming an average
proliferation rate of 1.5%/day, islands should
show rapid growth even without promotion with a
doubling time of about 45 days (Fig. 5). However,
the growth rate of the average island actually found
was almost zero for several months and then in-
creased gradually (Figs. 4 and 5). Thus it appears
that the altered cells have a life-time shorter than
that of normal hepatocytes, which is several hun-
dred days. Alternatively, the island cells may "re-
model" to a phenotype indiscriminable from normal
hepatocytes.
Long-term effects of promoters on island develop-
ments were studied in two different experimental
designs. In the first design, two suspected tumor
promoters, i.e., CPA and progesterone (Pro), were
given intermittently once per week; in the other,
phenobarbital or a-HCH was administered continu-
ously via the food.
Intermittent treatment with Pro or CPA caused
strikingly enhanced DNA synthesis rates in islands
at each time investigated. The upper part of Figure
4 shows, as an example, 3H-indices found after 6
months of treatment. This effect was associated
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with increases in the average island volume (Fig. 4,
middle part). Island enlargement precedes the ap-
pearance of neoplastic nodules in the hormone-
treated rats (Fig. 4, lower part). These findings
strongly suggest that CPA and Pro promote tumor
development in rat liver and that hormone-induced
increases of island cell proliferation are at least par-
tially responsible for island enlargement under the
present conditions. Moreover, the findings are con-
sistent with the hypothesis that island enlargement
is a rate-limiting factor in liver tumorigenesis. In
addition, we noted an increase in the number of
detectable islands (18).
Results obtained after continuous treatment with
phenobarbital are presented in Figure 5. Since the
effects of a-HCH were qualitatively very similar
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FIGURE 4. Effects ofintermittent treatment with cyproterone
acetate and progesterone on island growth and tumor
appearance following initiation by a single dose of NNM.
Promoter treatment was started at time "O". Hatched
columns: normal hepatocytes; black columns: y-GT positive
island cells.
44
24
14
LIVER DNA
(mg /bOOg b w.)
S N NNMPPB a
_-~=~ O*\ 0
* -
* NNM
% T DNA SYNTHESIS
pl ( I OF ISLAND CELLS)
NNM*PB
NMt
I
3 6 9 12 MONTHS 15
NNM
_-calc.1.5 1 )
AVERAGE CELL NUMBER - a
PER ISLAND CROSSCSECTIONRSEO,
- / NNM*PL
C
_- - - C
/ NNM
a
NO OF ISLAND/CM
-I 2 ~~~~~NNMl.pB 8*P
1~~~~~~~~~
6 --0 :1 =" -
I U NNM
N1 NNM
3 5 7 9 11MONTHS 14
d
FIGURE 5. Effects ofcontinuous treatment with phenobarbital
on (a) liver DNA, (b) island DNA synthesis, (c) island size
and (d) island number following initiation by a single dose of
NNM administered at zero time. PB treatment started 2
months after NNM. ( ) theoretical island growth rate
assuming cell replication of1.5%/day.
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though somewhat more pronounced with respect to
all parameters studied they are not shown. The he-
patic content of DNA was increased at all times in-
vestigated (Fig. 5a). DNA synthesis in normal hepa-
tocytes, after a small initial rise, was essentially the
same as in untreated rats as expected (data not
shown); in island cells it was increased initially but
rapidly declined to the level found in islands of un-
treated rats (Fig. 5b). This suggests that DNA syn-
thesis in the average island, though it remains at a
higher level than in normal cells, is sensitive to
feedback control of hepatocyte proliferation (8).
Average size and number of islands both increased
severalfold during phenobarbital treatment as ob-
served before (19). While the increase in number al-
ready appeared in the early weeks of promotion, is-
land enlargement was detectable only after some
delay (Figs. 5c and 5d). The size distribution of is-
lands after 28 weeks of treatment with phenobarbi-
tal or a-HCH is shown in Figure 6.
How can these findings be explained? It appears
that increased island cell proliferation cannot be
the only factor responsible for island enlargement
during continuous exposure to a-HCH and pheno-
barbital. We therefore assume that under these con-
ditions island growth is due to a decrease in the
rates of cell death or phenotypic remodeling, either
of which appears to occur in island cells (see above).
This assumption seems reasonable since prevention
of cell death has been observed to be one of the pro-
moter effects in normal liver (Fig. 2) and since pro-
moters have already been shown to prevent pheno-
typic changes in islands (20). The increased number
of islands should partially result from island en-
largement which increases the probability of detec-
tion, and partially from growth of miniislands and
single initiated cells to a detectable size. This would
No. of islands/cm2
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mean island size(cells/island cross-sections)
FIGURE 6. Island size distribution after 28 weeks of con-
tinuous treatment with phenobarbital and a-HCH.
imply that a considerable number of initiated hepa-
tocytes do not proliferate to form detectable islands
unless a promoter is applied. In addition, promoters
may possibly lead to phenotypic changes within ex-
isting but undetectable islands in a non- promoted
liver in such a way that they are more clearly de-
marcated from the surrounding normal tissue.
These considerations are supported by findings
obtained after withdrawal of PB (Fig. 5). The total
DNA content of the liver returned to the control
level although more slowly than in the experiment
presented in Figure 2. In parallel, number and
average size of islands returned to the levels found
in nonpromoted animals (Figs. 5c, d). Some of the re-
sidual islands exhibited signs of phenotypic rever-
sion to a more normal appearance, such as partial
loss of y-GT. Thus both remodeling of island cells to
the normal phenotype and island cell death (sug-
gested by the loss of liver DNA) may have contrib-
uted to the decreases of island size and number. In
any event part of the island cells found after a per-
iod of promotion seem to be promoter-dependent for
survival or specific phenotypic appearance. These
results are compatible with the assumption that PB
induces growth of a subpopulation of promoter-de-
pendent islands. The basic defect in this subpopula-
tion would be a persisting imbalance of cell prolifer-
ation vs. cell death/remodeling during prolonged
promoter treatment when the normal liver has
reached a new steady state of cell number (see
above). This property seems to be different from
another feature of putative initiated cells, i.e. resis-
tance which is thought responsible for island growth
during promotion with AAF (15, 21).
The regression of islands after promoter with-
drawal is of considerable interest from a practical
toxicological point of view, since it confirms pre-
vious findings made with skin tumors suggesting
that the action of a promoter is reversible within
certain limits.
We conclude that the ability to induce liver
growth or the hormonelike effect is an essential,
though not necessarily the only critical property of
the tumor promoters. Island cells have a prolifera-
tion advantage over normal hepatocytes; tumor pro-
moters seems to enhance the manifestation of this
advantage. Properties of promoters and of putative
preneoplastic islands relevant for tumor promotion
and also of possible help for identification of both
are listed in Tables 2 and 3.
Growth Control in Foci of Altered Cells
By using the procedures described above it is
possible to study features of growth control of puta-
tive preneoplastic hepatocytes. Despite of their in-
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creased proliferative activity (see above), these cells
are not autonomous with respect to growth control.
First, their proliferation rate, although higher than
in normal liver cells, is still much lower than in liver
lesions further advanced towards the malignant
state. Second, island cells appear to respond to
feedback inhibition of DNA synthesis during
prolonged promoter treatment (Fig. 5) as do normal
liver cells (Figs. 1, 2). Third, island cells seem to de-
pend as normal cells on permissive signals released
by consumption of food: In normal hepatocytes, food
consumption has been found to control the induction
of cell replication by mitogens at two specific stages
before and during the replicative cycle, i.e. in the Go
phase and in the R phase, several hours before initi-
ation of DNA synthesis. Fasting in one of these
phases makes the liver nonresponsive to the mito-
genic effect of the agents. Thus in addition to the
specific mitogenic signal exerted by the mitogens
cell replication in the liver depends on the pres-
ence of permissive signals which are released after
food consumption (Fig. 7) (6, 22). As shown in Figure
8, fasting in either the Go or R state largely sup-
presses DNA synthesis in foci of altered cells simi-
lar as in normal liver cells. In conclusion, with re-
spect to their proliferative behavior, island cells ap-
pear to be in a state between normalcy and malig-
nancy. The basic defect which renders island cells
more susceptible to endogenous and exogenous mi-
togenic stimuli is still unknown.
Table 2. Properties of liver tumor promoters.
Property
Induce ofgrowth and functional changes in the liver (hormone-
like effect)
Enhanced proliferation ofputative preneoplastic cells
Accelerate growth ofputative preneoplastic islands
Produce histochemical/morphological changes in putative
preneoplastic islands
Accelerate appearance oftumors
Table 3. Properties ofcells in islands ofaltered (initiated)
hepatocytes which are relevant to island growth.
Property
Proliferation rate in excess ofhomeostatic need ofthe whole
liver
Short lifespan and/or phenotypic instability
Response to liver tumor promoters:
Increase ofproliferation rate
Increase oflifespan and/or prevention ofphenotypic
reversion
Sensitivity to feedback-inhibition ofcell proliferation
Dependence on permissive signals exerted by food con-
sumption
Progression
If some or all of the foci of altered cells are poten-
tial intermediates on the pathway to cancer, pro-
gression to more malignant phenotypes should oc-
casionally occur within islands. This has been ob-
served by others (21) and also in the present study.
Progression may be due to a (rare) event similar to
that causing initiation (21). Qn the basis of our find-
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FIGURE 7. Scheme showing interactions between feeding and
hepatomitogens in the control of the hepatic replicative
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FIGURE 8. Effect of fasting during the G. and R phase of the
replicative cycle on DNA synthesis in foci of altered
hepatocytes.
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FIGURE 9. Islands of altered cells in the liver of an untreated 2-year-old Wistar rat: (top) 25 x (bottom) 180 x . Note the pres-
ence of numerous island cells labelled with silver grains indicating DNA replication.
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ings we propose the hypothesis that the relatively
high replicative activity of island cells may be re-
sponsible for progression. Since cell replication
seems necessary to fix any damage potentially
leading to initiation (or progression), the chances of
fixation of critical damage are much higher in is-
lands than in normal liver. Moreover, replication it-
self carries a certain risk of errors which occasion-
ally may lead to progression. In the adult rat, the
frequency of abnormal, erroneous mitoses report-
edly is high even in the noninitiated liver (23).
Due to the increased proliferative activity, an is-
land liver cell may replicate about 10 times a year,
while a normal liver cell would replicate approxi-
mately once. Thus the average island cell should
have a much higher risk of initiationlike phenotypic
changes than the normal hepatocyte. Multiplication
and enlargement of islands during promotion dra-
matically expands the population "at risk;" as a re-
sult, a rare event leading to progression is much
more likely to occur at an early time than in nonpro-
moted liver.
Effect of Promoters on Islands Appearing
Spontaneously
As mentioned above, tumors may occasionally de-
velop after sole treatment with a promoter without
initiating pretreatment. This finding has similarly
been made with the promoters par excellence, i.e.,
the phorbol esters, in studies on skin tumorigenesis
and has supported doubts expressed by several
workers on the validity of the promotion concept.
The defenders of the concept explained the forma-
tion of tumors by promoters alone by assuming pro-
motion of spontaneous initiated cells, but to our
knowledge this claim has not yet found much exper-
imental support.
We have searched for putatively initiated cells in
the liver of 2-year-old Wistar rats, using for identifi-
cation the proliferative characteristics of carcino-
gen-induced island cells, in addition to the usual
morphological and histochemical markers. Although
the Wistar substrain used has a low background of
spontaneous hepatoma (2%), all of 41 animals stu-
died had in the liver islands of altered cells which
on the basis of histochemical, morphological and
functional criteria (increased cell proliferation) were
very similiar if not identical to those produced in
young animals by application of hepatocarcinogens
(Fig. 9). As shown in Figure 10 these "spontaneous"
islands exhibit an increased rate of DNA synthesis
over that of normal hepatocytes. Most importantly,
various different liver tumor promoters cause a fur-
ther increase of the DNA replication rate; this
shows that the "spontaneous" islands are respon-
25 DNASyntSiS(SpontaneouS iSlandS)
FIGURE 10. DNA synthesis in "spontaneous" foci of altered
cells: (Black) normal cells; (cross-hatched) y-GT positive
islands. Treatment: see text, methods and Fig. 3.
sive to the mitogenic effects of the tumor pro-
moters. Prolonged application of the promoters
therefore should result in rapid island growth and
eventually in tumor formation.
This finding implies that long-term carcinogenic-
ity bioassays of chemical agents do not discrimi-
nate between initiating and promoting properties of
a test compound, if preneoplastic lesions develop
spontaneously in the affected organ. Obviously addi-
tional tests are required for reliable interpretation
of data and risk assessment. The properties of tu-
mor promoters listed in Table 2 would appear to
provide useful parameters for the detection of pro-
moting agents. In particular the observed enhance-
ment of proliferation of island cells in response to
tumor promoters might provide a useful and reli-
able shortterm test in vivo. This possibility will be
checked in further studies.
In view of the ubiquitous presence of a vast num-
ber of carcinogenic factors in our environment the
formation of initiated cells may be a frequent event
in the liver and in other organs of animals and hu-
mans. According to some current evaluations of
long-term carcinogenicity, a number of drugs and
other chemicals including various natural and syn-
thetic hormones have been classified as (initiating)
carcinogens. However, several of these agents in-
duce growth and promote tumor development in
their target organs. On the basis of the present re-
sults it is tempting to consider the possibility that
promotion of spontaneous initiated cells may ex-
plain the development of cancer by nonmutagenic
drugs and hormones in various organs of animals
and humans.
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